Search
Legend Biotech Corp
LEGNAdd to Watchlist
27.930USD
-5.590-16.68%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
5.19BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Legend Biotech Corp is 8.35, ranking 135 out of 389 in the Biotechnology & Medical Research industry. The average price target is 74.00, with a high of 91.00 and a low of 48.00.
Analyst Rating
Based on
17
analysts
Buy
Current Rating
59.725
Target Price
+113.84%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Legend Biotech Corp
LEGN
17
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Legend Biotech Corp's expected revenue for the next quarter?
Legend Biotech Corp's expected revenue is 363.01M.
What is Legend Biotech Corp's price target?
Analysts forecast that Legend Biotech Corp's price target is USD 74.00, with the highest forecast at USD 91.00 and the lowest forecast at USD 48.00.
How have Legend Biotech CorpLEGN's recent earnings per share performed?
The market expectation was USD -0.29, while Legend Biotech CorpLEGN's earnings per share (EPS) for the previous quarter was USD -0.17. EPS for the next quarter is expected at USD 0.10.
What is the analyst rating for Legend Biotech Corp?
Based on the ratings of Legend Biotech Corp's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
